These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 22610258)

  • 1. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
    Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
    J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
    Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
    J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
    Robinson BM; Kennedy C; McLean J; McCaughan BC
    J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
    Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
    Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoidal reactions in regional lymph nodes of patients with early stage non-small cell lung cancer predict improved disease-free survival: a pilot case-control study.
    Steinfort DP; Tsui A; Grieve J; Hibbs ML; Anderson GP; Irving LB
    Hum Pathol; 2012 Mar; 43(3):333-8. PubMed ID: 21835432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
    Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
    J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
    Bergman P; Brodin D; Lewensohn R; de Petris L
    Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
    J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
    J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.